Doctor Sampsa Kinos

Tampere University Hospital, Tampere (Finland)

Follow

Contributor content

Safety and efficacy of S-1-based treatment in colorectal cancer patients who switched to S-1 after development of cardiotoxicity on fluoropyrimidine-based adjuvant or neoadjuvant treatment

Presentation

Safety and efficacy of S-1-based treatment in colorectal cancer patients who switched to S-1 after development of cardiotoxicity on fluoropyrimidine-based adjuvant or neoadjuvant treatment

ESC 365 is supported by

novartis

Explore sponsored resources